Glucosteril (Glucose Monohydrate)

Glucosteril is employed as a component of intravenous nutrition regimens and as a source of rapid carbohydrate supplementation. It may be used in clinical settings where patients require energy support through the bloodstream.

• Supplemental carbohydrate source in total parenteral nutrition (TPN)
• Energy provision during perioperative fasting
• Management of hypoglycemia when oral intake is not possible
• Support for patients with increased metabolic demand
• Adjunct in fluid resuscitation protocols requiring caloric input

Glucosteril is generally well tolerated, but adverse reactions can occur. Reported events are categorized by frequency and severity.

Common

• Local irritation at the injection site
• Mild hyperglycemia
• Transient electrolyte shifts
• Nausea or vomiting
• Headache

Serious

• Severe hyperglycemia leading to osmotic diuresis
• Allergic reaction or anaphylaxis
• Metabolic acidosis in susceptible patients
• Fluid overload with pulmonary edema

When using Glucosteril, clinicians should consider patient-specific factors and monitor relevant parameters to minimize risks.

• Assess blood glucose levels before and during infusion
• Adjust dosage in patients with renal or hepatic impairment
• Monitor for signs of fluid overload, especially in heart failure
• Use caution in diabetic patients or those on insulin therapy
• Verify compatibility with other intravenous solutions
• Ensure aseptic technique to prevent infection
• Document any adverse reactions promptly

Glucosteril may interact with other medications or solutions administered intravenously. Awareness of these interactions helps maintain safety.

Avoid

• Co-administration with high‑dose insulin without glucose monitoring
• Mixing with incompatible electrolytes that may precipitate
• Simultaneous infusion of hypertonic dextrose solutions exceeding recommended concentrations

Use with caution

• Concurrent use of diuretics that affect fluid balance
• Medications that alter glucose metabolism (e.g., glucocorticoids)
• Intravenous lipid emulsions that may affect caloric calculations
• Drugs that require strict electrolyte control (e.g., potassium‑sparing agents)